Current laser treatments for benign prostatic hyperplasia

Korean Journal of Urology

Volumn 51, Issue 11, 2010, Pages 737-744

  Son, Hwancheol ^a   Song, Sang Hoon ^b   Paick, Jae Seung ^c  

^a Seoul National University Boramae Hospital   (South Korea)

^b Jeungpyung Health Center   (South Korea)

^c Seoul National University College of Medicine   (South Korea)

Author keywords

Laser therapy; Prostatic hyperplasia; Solid state lasers

Indexed keywords

BLOOD TRANSFUSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HOLMIUM LASER; HOLMIUM LASER ENUCLEATION OF THE PROSTATE; HOSPITALIZATION; HUMAN; INTERMETHOD COMPARISON; LAPAROSCOPIC SURGERY; LASER SURGERY; MALE; META ANALYSIS; PATIENT SAFETY; PHOTOSELECTIVE VAPORIZATION OF THE PROSTATE; POSTOPERATIVE COMPLICATION; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATECTOMY; RANDOMIZED CONTROLLED TRIAL; REVIEW; ROBOTICS; SYSTEMATIC REVIEW; TRANSURETHRAL RESECTION;

EID: 78649641133     PISSN: 20056737     EISSN: 20056745     Source Type: Journal    
DOI: 10.4111/kju.2010.51.11.737     Document Type: Review

References (73)

1. Mebust WK, Holtgrewe HL, Cockett AT, Peters PC. Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients. J Urol 1989;141:243-7.
2. Reich O, Bachmann A, Schneede P, Zaak D, Sulser T, Hofstetter A. Experimental comparison of high power (80 W) potassium titanyl phosphate laser vaporization and transurethral resection of the prostate. J Urol 2004;171:2502-4. (Pubitemid 38625524)
3. Kuntz RM. Laser treatment of benign prostatic hyperplasia. World J Urol 2007;25:241-7.
4. Kang HW, Jebens D, Malek RS, Mitchell G, Koullick E. Laser vaporization of bovine prostate: a quantitative comparison of potassium- titanyl-phosphate and lithium triborate lasers. J Urol 2008;180:2675-80.
5. Malek RS, Barrett DM, Kuntzman RS. High-power potassium-titanyl- phosphate (KTP/532) laser vaporization prostatectomy: 24 hours later. Urol 1998;51:254-6.
6. Park JH, Son H, Paick JS. Comparative analysis of the efficacy and safety of photoselective vaporization of the prostate for treatment of benign prostatic hyperplasia according to prostate size. Korean J Urol 2010;51:115-21.
7. Kauffman EC, Kang HW, Choi BB. The effect of laser-fiber sweeping speed on the efficiency of photoselective vaporization of the prostate in an ex vivo bovine model. J Endourol 2009;23:1429-35.
8. Hoekstra RJ, van Melick HH, Kok ET, Ruud Bosch JL. A 10-year follow-up after transurethral resection of the prostate, contact laser prostatectomy and electrovaporization in men with benign prostatic hyperplasia; long-term results of a randomized controlled trial. BJU Int 2010;106:822-6.
9. Ku JH, Cho JY, Cho SY, Kim SW, Paick JS. The one year outcome after KTP laser vaporization of the prostate according to the calculated vaporized volume. J Korean Med Sci 2009;24:1187-91.
10. Alivizatos G, Skolarikos A. Greenlight laser in benign prostatic hyperplasia: turning green into gold. Curr Opin Urol 2008;18:46-9. (Pubitemid 350307530)
11. Sulser T, Reich O, Wyler S, Ruszat R, Casella R, Hofstetter A, et al. Photoselective KTP laser vaporization of the prostate: first experiences with 65 procedures. J Endourol 2004;18:976-81. (Pubitemid 40070908)
12. Choo SH, Han DH, Lee SW. The efficacy and safety of KTP photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: the 2-year results. Korean J Urol 2008;49:831-6.
13. Lee J, Kang SH, Kim JJ. Evaluation of the quality of life and the efficacy of treatment after high power potassium-titanyl-phosphate (KTP) laser vaporization for patients with a prostate volume greater than 40cc. Korean J Urol 2007;48:956-64. (Pubitemid 47496988)
14. Hwang CH, Cho CK, Lee YK, Hong SJ. Comparative analysis of short-term efficacy and complication of photoselective vaporization for benign prostatic hyperplasia which was classified by prostate size. Korean J Urol 2007;48:826-31.
15. Hwang EC, Joo JS, Min KD, Oh BR, Kang TW, Kwon DD, et al. A short-term comparative study on efficacy and safety of standard transurethral resection and high power (80W) potassium-titanyl-phosphate laser vaporization of the prostate. Korean J Urol 2005;46:1251-5.
16. Rajbabu K, Chandrasekara SK, Barber NJ, Walsh K, Muir GH. Photoselective vaporization of the prostate with the potassium-titanyl-phosphate laser in men with prostates of >100 mL. BJU Int 2007;100:593-8. (Pubitemid 47205451)
17. Pfitzenmaier J, Gilfrich C, Pritsch M, Herrmann D, Buse S, Haferkamp A, et al. Vaporization of prostates of >?or =80 mL using a potassium-titanyl- phosphate laser: midterm-results and comparison with prostates of <80 mL. BJU Int 2008;102:322-7. (Pubitemid 352019188)
18. Sandhu JS, Ng CK, Gonzalez RR, Kaplan SA, Te AE. Photoselective laser vaporization prostatectomy in men receiving anticoagulants. J Endourol 2005;19:1196-8.
19. Fu WJ, Hong BF, Wang XX, Yang Y, Cai W, Gao JP, et al. Evaluation of greenlight photoselective vaporization of the prostate for the treatment of high-risk patients with benign prostatic hyperplasia. Asian J Androl 2006;8:367-71.
20. Reich O, Bachmann A, Siebels M, Hofstetter A, Stief CG, Sulser T. High power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate in 66 high risk patients. J Urol 2005;173:158-60. (Pubitemid 39627700)
21. Heinrich E, Schiefelbein F, Schoen G. Technique and short-term outcome of green light laser (KTP, 80W) vaporization of the prostate. Eur Urol 2007;52:1632-7. (Pubitemid 350052418)
22. Son H, Ro YK, Min SH, Choo MS, Kim JK, Lee CJ. Modified vaporization- resection for photoselective vaporization of the prostate using a greenlight™ high performance system 120W laser : the Seoul Technique. Urology 2010;Epub ahead of print
23. Araki M, Lam PN, Wong C. High-power potassium-titanyl-phosphate laser photoselective vaporization prostatectomy for symptomatic benign prostatic hyperplasia. J Endourol 2008;22:1311-4. (Pubitemid 351913512)
24. Te AE, Malloy TR, Stein BS, Ulchaker JC, Nseyo UO, Hai MA, et al. Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: 12-month results from the first United States multicenter prospective trial. J Urol 2004;172:1404-8.
25. Ruszat R, Wyler SF, Seitz M, Lehmann K, Abe C, Bonkat G, et al. Comparison of potassium-titanyl-phosphate laser vaporization of the prostate and transurethral resection of the prostate: update of a prospective non-randomized two-centre study. BJU Int 2008;102:1432-8.
26. Tugcu V, Tasci AI, Sahin S, Zorluoglu F. Comparison of photoselective vaporization of the prostate and transurethral resection of the prostate: a prospective nonrandomized bicenter trial with 2-year follow-up. J Endourol 2008;22:1519-25.
27. Spaliviero M, Araki M, Culkin DJ, Wong C. Incidence, management, and prevention of perioperative complications of GreenLight HPS laser photoselective vaporization prostatectomy: experience in the first 70 patients. J Endourol 2009;23:495-502.
28. Kim HS, Cho MC, Ku JH, Kim SW, Paick JS. The efficacy and safety of photoselective vaporization of the prostate with a potassium- titanyl-phosphate laser for symptomatic benign prostatic hyperplasia according to prostate size: 2-year surgical outcomes. Korean J Urol 2010;51:330-6.
29. Ku JH, Kim SW, Paick JS. Impact of prostate volume on the efficacy of high-power potassium-titanyl-phosphate photoselective vaporization of the prostate: a retrospective, short-term follow-up study on evaluating feasibility and safety. Yonsei Med J 2010;51:877-82.
30. Lee CJ, Cho MC, Ku JH, Kim SW, Paick JS. Changes in nocturia after photoselective vaporization of the prostate for patients with benign prostatic hyperplasia. Korean J Urol 2010;51:531-6.
31. Malek RS, Kuntzman RS, Barrett DM. Photoselective potassium-titanyl- phosphate laser vaporization of the benign obstructive prostate: observations on long-term outcomes. J Urol 2005;174:1344-8.
32. Hai MA. Photoselective vaporization of prostate: five-year outcomes of entire clinic patient population. Urology 2009;73:807-10.
33. Reich O, Bachmann A, Siebels M, Hofstetter A, Stief CG, Sulser T. High power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate in 66 high risk patients. J Urol 2005;173:158-60. (Pubitemid 39627700)
34. Bachmann A, Schürch L, Ruszat R, Wyler SF, Seifert HH, Müller A, et al. Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi-centre study of perioperative morbidity and early functional outcome. Eur Urol 2005;48:965-71.
35. Sandhu JS, Ng C, Vanderbrink BA, Egan C, Kaplan SA, Te AE. High-power potassium-titanyl-phosphate photoselective laser vaporization of prostate for treatment of benign prostatic hyperplasia in men with large prostates. Urology 2004;64:1155-9. (Pubitemid 39647058)
36. Bouchier-Hayes DM, Anderson P, Van Appledorn S, Bugeja P, Costello AJ. KTP laser versus transurethral resection: early results of a randomized trial. J Endourol 2006;20:580-5. (Pubitemid 44689646)
37. Chandrasekera S, Muir G. Potassium titanyl phosphate laser prostatectomy: a review. Curr Opin Urol 2007;17:22-6. (Pubitemid 44901086)
38. Madersbacher S, Lackner J, Brössner C, Röhlich M, Stancik I, Willinger M, et al. Reoperation, myocardial infarction, and mortality after transurethral and open prostatectomy: a nation-wide, long term analysis of 23,123 cases. Eur Urol 2005;47:499-504. (Pubitemid 40357897)
39. Dixon, CM. Lasers for the treatment of benign prostatic hyperplasia. Urol clin North Am 1995;22:413-22.
40. Chun SS, Razvi HA, Denstedt JD. Laser prostatectomy with the holmium:YAG laser. Tech Urol 1995;1:217-21.
41. Gilling PJ, Cass CB, Malcolm AR, Fraundorfer MR. Combination holmium and Nd:YAG laser ablation of the prostate: initial clinical experience. J Endourol 1995;9:151-3.
42. Wollin TA, Denstedt JD. The holmium laser in urology. J Clin Laser Med Surg 1998;16:13-20.
43. Larizgoitia I, Pons JM. A systematic review of the clinical efficacy and effectiveness of the holmium:YAG laser in urology. BJU Int 1999;84:1-9. (Pubitemid 29346764)
44. Gilling PJ, Fraundorfer MR. Holmium laser prostatectomy: a technique in evolution. Curr Opin Urol 1998;8:11-5.
45. Kuntz RM, Lehrich K, Ahyai S. Transurethral holmium laser enucleation of the prostate compared with transvesical open prostatectomy: 18-month follow-up of a randomized trial. J Endourol 2004;18:189-91.
46. Moody J, Lingeman JE. Holmium laser enucleation for prostate adenoma greater than 100 gm.: comparison to open prostatectomy. J Urol 2001;165:459-62. (Pubitemid 32060436)
47. Ruszat R, Seitz M, Wyler SF, Müller G, Rieken M, Bonkat G, et al. Prospective single-centre comparison of 120-W diode-pumped solid-state high-intensity system laser vaporization of the prostate and 200-W high-intensive diode-laser ablation of the prostate for treating benign prostatic hyperplasia. BJU Int 2009;104:820-5.
48. Kuo RL, Paterson RF, Siqueira TM Jr, Watkins SL, Simmons GR, Steele RE, et al. Holmium laser enucleation of the prostate: morbidity in a series of 206 patients. Urology 2003;62:59-63. (Pubitemid 36802072)
49. Kuo RL, Kim SC, Lingeman JE, Paterson RF, Watkins SL, Simmons GR, et al. Holmium laser enucleation of the prostate (HoLEP): the Methodist hospital experience with greater than 75 gram enucleations. J Urol 2003;170:149-52.
50. Elzayat EA, Habib EI, Elhilali MM. Holmium laser enucleation of the prostate: a size-independent new "gold standard". Urology 2005;66(5 Suppl):108-13.
51. Elzayat EA, Elhilali MM. Holmium laser enucleation of the prostate (HoLEP): the endourological alternative to open prostatectomy. Eur Urol 2006;49:87-91. (Pubitemid 41789961)
52. Du C, Jin X, Bai F, Qiu Y. Holmium laser enucleation of the prostate: the safety, efficacy, and learning experience in China. J Endourol 2008;22:1031-6. (Pubitemid 351693926)
53. Gilling P. Holmium laser enucleation of the prostate (HoLEP). BJU Int 2008;101:131-42.
54. Ahyai SA, Lehrich K, Kuntz RM. Holmium laser enucleation versus transurethral resection of the prostate: 3-year follow-up results of a randomized clinical trial. Eur Urol 2007;52:1456-63.
55. Kuntz RM, Lehrich K, Ahyai SA. Holmium laser enucleation of the prostate versus open prostatectomy for prostates greater than 100 grams: 5-year follow-up results of a randomized clinical trial. Eur Urol 2008;53:160-6.
56. Naspro R, Suardi N, Salonia A, Scattoni V, Guazzoni G, Colombo R, et al. Holmium laser enucleation of the prostate versus open prostatectomy for prostates >70 g: 24-month follow-up. Eur Urol 2006;50:563-8.
57. Wilson LC, Gilling PJ, Williams A, Kennett KM, Frampton CM, Westenberg AM, et al. A randomized trial comparing holmium laser enucleation versus transurethral resection in the treatment of prostates larger than 40 grams: results at 2 years. Eur Urol 2006;50:569-73. (Pubitemid 44189064)
58. Gupta N, Sivaramakrishna, Kumar R, Dogra PN, Seth A. Comparison of standard transurethral resection, transurethral vapour resection and holmium laser enucleation of the prostate for managing benign prostatic hyperplasia of >40g. BJU Int 2006;97:85-9.
59. Naspro R, Bachmann A, Gilling P, Kuntz R, Madersbacher S, Montorsi F, et al. A review of the recent evidence (2006-2008) for 532-nm photoselective laser vaporization and holmium laser enucleation of the prostate. Eur Urol 2009;55:1345-57.
60. Vavassori I, Hurle R, Vismara A, Manzetti A, Valenti S. Holmium laser enucleation of the prosate combined with mechanical morcellation: two years of experience with 196 patients. J Endourol 2004;18:109-12. (Pubitemid 38295674)
61. Peterson MR, Matlaga BR, Kim SC, Kuo RL, Soergel TM, Watkins SL, et al. Holmium laser enucleation of the prostate for men with urinary retention. J Urol 2005;174:998-1001. (Pubitemid 41140659)
62. Shah HN, Kausik V, Hegde S, Shah JN, Bansal MB. Evaluation of fluid absorption during holmium laser enucleation of prostate by breath ethanol technique. J Urol 2006;175:537-40. (Pubitemid 43067347)
63. Fried NM, Murray KE. High-power thulium fiber laser ablation of urinary tissues at 1.94 microm. J Endourol 2005;19:25-31.
64. Bach T, Herrmann TR, Ganzer R, Burchardt M, Gross AJ. RevoLix vaporesection of the prostate: initial results of 54 patients with an 1-year follow-up. World J Urol 2007;25:257-62.
65. Bach T, Herrmann TR, Ganzer R, Blana A, Burchardt M, Gross AJ. Thulium:YAG vaporesection of the prostate: first results. Urologe A 2009;48:529-34.
66. Bach T, Wendt-Nordahl G, Michel MS, Herrmann TR, Gross AJ. Feasibility and efficacy of Thulium: YAG laser enucleation (VapoEnucleation) of the prostate. World J Urol 2009;27:541-5.
67. Bach T, Herrmann TR, Haecker A, Michel MS, Gross A. Thulium:yttrium- aluminium-garnet laser prostatectomy in men with refractory urinary retention. BJU Int 2009;104:361-4.
68. Bach T, Netsch CH, Haecker A, Michel MS, Herrmann TR, Gross AJ. Thulium:YAG laser enucleation (VapoEnucleation) of the prostate: safety and durability during intermediate-term follow-up. World J Urol 2010;28:39-43.
69. Gordon S, Watson G. Thulium laser enucleation of the prostate. Eur Urol 2006;5(Suppl):310.
70. Mattioli S, Munoz R, Recasens R, Berbegal C, Cortada J, Urmeneta JM, et al. Treatment of benign prostatic hyperplasia with the Revolix laser. Arch Esp Urol 2008;61:1037-43.
71. Seitz M, Ruszat R, Bayer T, Tilki D, Bachmann A, Stief C, et al. Ex vivo and in vivo investigations of the novel 1,470 nm diode laser for potential treatment of benign prostatic enlargement. Lasers Med Sci 2009;24:419-24.
72. Leonardi R. Preliminary results on selective light vaporization with the side-firing 980 nm diode laser in benign prostatic hyperplasia: an ejaculation sparing technique. Prostate Cancer Prostatic Dis 2009;12:277-80.
73. Chiang PH, Chen CH, Kang CH, Chuang YC. GreenLight HPS laser 120-W versus diode laser 200-W vaporization of the prostate: comparative clinical experience. Lasers Surg Med 2010;42:624-9.